AIM-100 NEW
| Price | $42 | $68 | $105 |
| Package | 2mg | 5mg | 10mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-27 |
Product Details
| Product Name: AIM-100 | CAS No.: 873305-35-2 |
| Purity: 98.91% | Supply Ability: 10g |
| Release date: 2026/07/27 |
Product Introduction
Bioactivity
| Name | AIM-100 |
| Description | AIM-100 is a Ack1 inhibitor (IC50: 24 nM). |
| In vitro | AIM-100 not only inhibited Ack1 activation but also suppressed AKT tyrosine phosphorylation, leading to cell cycle arrest in the G1 phase [1]. It also was able to suppress AR Tyr(267) phosphorylation and its recruitment to the ATM enhancer. Notably, AIM-100 suppressed Ack1 mediated ATM expression and mitigated the growth of radioresistant CRPC tumors [2]. AIM-100, not only inhibited Ack1 activation but also able to suppress pTyr267-AR phosphorylation, binding of AR to PSA, NKX3.1, and TMPRSS2 promoters, and inhibit AR transcription activity [3]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (5.38 mM), Sonication is recommended. DMSO : 60 mg/mL (161.54 mM), Sonication is recommended. Ethanol : 30 mg/mL (80.77 mM), Sonication is recommended. |
| Keywords | Tyr-phosphorylation | Tyr267 | TNK2 | TMPRSS2 | PSA | NKX3.1 | Inhibitor | inhibit | ATM | anticancer | AIM-100 | AIM 100 | Activated Cdc42 kinase 1 | Ack1 |
| Inhibitors Related | Ack1 inhibitor 1 | Vemurafenib | GNF-7 | 7PPD-Q | Ack1 inhibitor 2 | KRCA-0008 | EGFR/ACK1-IN-1 | (R)-9b | AZ7550 |
| Related Compound Libraries | Target-Focused Phenotypic Screening Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Tyrosine Kinase Inhibitor Library | Kinase Inhibitor Library | Bioactive Compound Library Plus | Inhibitor Library | NO PAINS Compound Library | Bioactive Compounds Library Max | Anti-COVID-19 Compound Library | Anti-Cancer Compound Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY